de Bruin M, Smid K, Laan A C, Noordhuis P, Fukushima M, Hoekman K, Pinedo H M, Peters G J
Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands.
Biochem Biophys Res Commun. 2003 Feb 14;301(3):675-9. doi: 10.1016/s0006-291x(03)00022-6.
Platelet derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) catalyzes the phosphorolysis of thymidine (TdR) to thymine and deoxyribose-1-phosphate (dR-1-P) and has a pro-angiogenic effect for which dR-1-P may be responsible. Using a purine nucleoside phosphorylase based assay it was found that TdR incubation did not increase dR-1-P accumulation in colon cancer cell line Colo320 and its PD-ECGF/TP transfected variant Colo320TP1. The assay was linear up to 25,000pmol dR-1-P with complete recovery of dR-1-P from cellular extracts. There was a huge discrepancy between thymine production and the measured dR-1-P level, 0.05% of the expected value for dR-1-P was found, indicating that there was a rapid disappearance of dR-1-P. However, in cellular extracts, TdR incubation increased dR-1-P, measurable by trapping, which was inhibited by a thymidine phosphorylase inhibitor. dR-1-P directly added to cellular extracts disappeared within 5-10min. In conclusion, large amounts of dR-1-P are produced by Colo320TP1 cells, which rapidly disappear thus not resulting in a net accumulation of dR-1-P in these cells.
血小板衍生内皮细胞生长因子/胸苷磷酸化酶(PD-ECGF/TP)催化胸苷(TdR)磷酸解生成胸腺嘧啶和脱氧核糖-1-磷酸(dR-1-P),并具有促血管生成作用,可能由dR-1-P介导。采用基于嘌呤核苷磷酸化酶的检测方法发现,TdR孵育并未增加结肠癌细胞系Colo320及其转染了PD-ECGF/TP的变体Colo320TP1中dR-1-P的积累。该检测方法在dR-1-P达到25,000pmol时呈线性,且能从细胞提取物中完全回收dR-1-P。胸腺嘧啶生成量与测得的dR-1-P水平之间存在巨大差异,仅发现dR-1-P预期值的0.05%,表明dR-1-P迅速消失。然而,在细胞提取物中,TdR孵育可增加dR-1-P,通过捕获法可检测到,且被胸苷磷酸化酶抑制剂所抑制。直接添加到细胞提取物中的dR-1-P在5-10分钟内消失。总之,Colo320TP1细胞产生大量dR-1-P,但这些dR-1-P迅速消失,因此在这些细胞中不会导致dR-1-P的净积累。